<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Indian J Ophthalmol</journal-id><journal-id journal-id-type="publisher-id">Indian Journal of Ophthalmology</journal-id><journal-title-group><journal-title>Indian Journal of Ophthalmology</journal-title></journal-title-group><issn pub-type="ppub">0301-4738</issn><issn pub-type="epub">1998-3689</issn><publisher><publisher-name>Medknow Publications</publisher-name><publisher-loc>India</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18417829</article-id><article-id pub-id-type="pmc">2636101</article-id><article-id pub-id-type="publisher-id">IndianJOphthalmol_2008_56_3_239_40367</article-id><article-id pub-id-type="pmid">18417829 </article-id><article-categories><subj-group subj-group-type="heading"><subject>Brief Communication</subject></subj-group></article-categories><title-group><article-title>Giant hanging melanoma of the eyelid skin</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Pai</surname><given-names>Radha R</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Kini</surname><given-names>Hema</given-names></name><degrees>MD</degrees></contrib><contrib contrib-type="author"><name><surname>Kamath</surname><given-names>Sai Giridhar</given-names></name><degrees>MS, FRCS</degrees></contrib><contrib contrib-type="author"><name><surname>Kumar</surname><given-names>Suneet</given-names></name><degrees>MBBS</degrees></contrib></contrib-group><aff>Departments of Pathology (RRP, HK, SK) and Ophthalmology (SGK),Kasturba Medical College, Mangalore, India</aff><author-notes><corresp id="cor1">Correspondence to: Dr. Radha R Pai, Department of Pathology,Kasturba Medical College, P. O. Box 53, Mangalore - 575 001, Karnataka,India. Email: <email>pairadharam@yahoo.co.in</email></corresp></author-notes><pub-date pub-type="ppub"><season>May-Jun</season><year>2008</year></pub-date><volume>56</volume><issue>3</issue><fpage>239</fpage><lpage>240</lpage><history><date date-type="received"><day>16</day><month>3</month><year>2007</year></date><date date-type="accepted"><day>31</day><month>7</month><year>2007</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Indian Journal of Ophthalmology</copyright-statement><copyright-year>2008</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/3.0"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><abstract><p>Cutaneous melanoma of the eyelid is a rare entity. We presenta 53-year-old male who had a nevus on the left upper eyelidskin since childhood, which transformed into a huge ulceratedhanging mass in the same region. Excision of the mass wasdone and histopathology confirmed the diagnosis of nodularmalignant melanoma. A small preauricular lymph node showedmetastatic melanoma on fine needle aspiration cytology.</p></abstract><kwd-group><kwd>Eyelid neoplasms</kwd><kwd>malignant melanoma</kwd></kwd-group></article-meta></front><body><p>Melanoma of the eyelid has an incidence of approximately 1%of all eyelid tumors, the conjunctival surface being excluded.<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref2">2</xref> Nodular melanoma of a large size arising and hanging fromthe skin of the upper eyelid as seen in this case, is an unusualfinding.</p><sec sec-type=""><title>Case Report</title><p>A 53-year-old male presented with an enlarging mass of theleft upper eyelid since one year. He gave history of a nevusin the same location since childhood. On examination, aprotuberant, nodular, ulcerated brown to black mass measuring5 &#x000d7; 4.5  &#x000d7; 4 cm was seen arising from the skin of the uppereyelid and hanging downwards over the cheek [<xref ref-type="fig" rid="F1">Fig. 1</xref>]. Thelid margin was not involved. The conjunctiva was normal.The best corrected visual acuity was 20/30 N6 and 20/40 N8in the right and left eyes respectively. Vision did not improvebeyond that due to nuclear sclerosis and posterior subcapsularcataract. A small preauricular lymph node was palpable on theleft side. Excision of the mass was done maintaining a marginof 8 mm around the tumor base to ensure adequate excision.There was loss of about three-fourths of the upper eyelid.Hence, for reconstruction a free tarsal graft was sourced fromthe right upper eyelid and sutured in position to the remnantof the tarsus on the excised eyelid of the left eye. The skin andorbicularis oculi muscle were undermined from the area abovethe eyelid and then advanced inferiorly to cover the tarsalgraft. Postoperative appearance was cosmetically acceptableand there was neither lagophthalmos nor corneal exposureon closure of the eye. Histopathologically, features were ofmalignant melanoma (Clark&#x02032;s level V, Breslow thickness 45 mm).Epithelioid and spindle tumor cells containing melanin pigmentwere seen with brisk mitoses (3 to 5 mitoses/high-power field)and junctional activity [<xref ref-type="fig" rid="F2">Fig. 2</xref>]. There was no evidence of thenevus. Nontumorogenic radial growth phase was absent. Fineneedle aspiration cytology of the preauricular lymph nodeshowed metastatic melanoma. The patient was briefed aboutadditional investigations for staging, further surgery andradiotherapy/chemotherapy as advised by the oncologist. Hewas not willing to undergo further treatment. Keeping in mindthe poor prognosis for survival in melanoma with metastasisthe patient was discharged after palliative surgery.</p></sec><sec sec-type=""><title>Discussion</title><p>Melanoma of the eyelid accounts for less than 7% of head andneck region cutaneous melanomas.<xref ref-type="bibr" rid="ref1">1</xref> The majority are seen inthe sixth to seventh decade of life. Either the upper or lowereyelid may be involved and predominantly it is of nodulartype.<xref ref-type="bibr" rid="ref1">1</xref>,<xref ref-type="bibr" rid="ref3">3</xref> To the best of our knowledge in the availableliterature, among the nodular melanomas the present case is the largest.<xref ref-type="bibr" rid="ref1">1</xref>-<xref ref-type="bibr" rid="ref3">3</xref>-<xref ref-type="bibr" rid="ref6">6</xref> The maximum size recorded is 40 &#x000d7; 42 mm but the type ofmelanoma is not mentioned.<xref ref-type="bibr" rid="ref6">6</xref> Among the different types ofmelanomas, lentigo maligna melanoma was among the largesttumors at presentation (750 mm<sup>2</sup>), which despite being thinner,was considered to be a greater surgical challenge.<xref ref-type="bibr" rid="ref7">7</xref> Melanomaof the eyelid skin has slightly better prognosis than itscounterpart elsewhere. Though melanomas developing at themucocutaneous lid margins were described to be at a greaterrisk of metastasis in one series,<xref ref-type="bibr" rid="ref1">1</xref> the same was not confirmedby the other.<xref ref-type="bibr" rid="ref3">3</xref> Simple thickness measurement is preferred tostage melanoma of the eyelid skin since the total dermis isexceptionally thin in this region and a Stage V melanoma onClark&#x02032;s scale would often be a much smaller lesion than such alesion at other sites.<xref ref-type="bibr" rid="ref7">7</xref> The recommended treatment is completesurgical excision with a margin of normal skin to surround thetumor. A narrow excision margin of 5 mm or less is associatedwith a greater frequency of recurrence.<xref ref-type="bibr" rid="ref7">7</xref> Regional lymph nodedissection in cases of completely excised cutaneous melanomaof head and neck did not result in increased survival, regardlessof depth of tumor invasion.<xref ref-type="bibr" rid="ref8">8</xref></p><p>About 15 months later the patient presented with markedenlargement of the left preauricular metastatic lymph node.There was no local recurrence. Clinically, there was no evidenceof metastatic disease at any other site. The patient refusedfurther radiological investigations and treatment.</p></sec></body><back><ref-list><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garner</surname><given-names>A</given-names></name><name><surname>Koorneef</surname><given-names>L</given-names></name><name><surname>Levene</surname><given-names>A</given-names></name><name><surname>Collin</surname><given-names>JR</given-names></name></person-group><article-title>Malignant melanomaof the eye lid skin: Histopathology and clinical behaviour</article-title><source>Br J Ophthalmol</source><year>1985</year><volume>69</volume><fpage>180</fpage><lpage>6</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sunderraj</surname><given-names>P</given-names></name></person-group><article-title>Malignant tumours of the eye and adnexa</article-title><source>Indian J Ophthalmol</source><year>1991</year><volume>39</volume><fpage>6</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">1894347</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grossniclaus</surname><given-names>HE</given-names></name><name><surname>McClean</surname><given-names>IW</given-names></name></person-group><article-title>Cutaneous melanoma of the eye lid-Clinicopathologic features</article-title><source>Ophthalmology</source><year>1991</year><volume>98</volume><fpage>1867</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">1775323</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tahery</surname><given-names>DP</given-names></name><name><surname>Goldberg</surname><given-names>R</given-names></name><name><surname>Moy</surname><given-names>RL</given-names></name></person-group><article-title>Malignant melanoma of the eyelid</article-title><source>J Am Acad Dermatol</source><year>1992</year><volume>27</volume><fpage>17</fpage><lpage>21</lpage><pub-id pub-id-type="pmid">1619070</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malhotra</surname><given-names>R</given-names></name><name><surname>Chen</surname><given-names>C</given-names></name><name><surname>Huilgol</surname><given-names>SC</given-names></name><name><surname>Hill</surname><given-names>DC</given-names></name><name><surname>Selva</surname><given-names>D</given-names></name></person-group><article-title>Mapped serialexcision for perioricular lentigo maligna and lentigo maligna melanoma</article-title><source>Ophthalmology</source><year>2003</year><volume>110</volume><fpage>2011</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">14522781</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>FM</given-names></name><name><surname>O&#x02032;Donnell</surname><given-names/></name><name><surname>Whitehead</surname><given-names>K</given-names></name><name><surname>Ryman</surname><given-names>W</given-names></name><name><surname>Sullivan</surname><given-names>TJ</given-names></name></person-group><article-title>Treatments and outcomes of malignant melanoma of the eyelid areview of 29 cases in Australia</article-title><source>Ophthalmology</source><year>2007</year><volume>114</volume><fpage>187</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">17140665</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vaziri</surname><given-names>M</given-names></name><name><surname>Buffam</surname><given-names>FV</given-names></name><name><surname>Martinka</surname><given-names>M</given-names></name><name><surname>Oryschak</surname><given-names>A</given-names></name><name><surname>Dhaliwal</surname><given-names>H</given-names></name><name><surname>White</surname><given-names>VA</given-names></name></person-group><article-title>Clinicopathologic features and behaviour of cutaneous eye lid melanoma</article-title><source>Ophthalmology</source><year>2002</year><volume>109</volume><fpage>901</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">11986095</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wanebo</surname><given-names>HJ</given-names></name><name><surname>Cooper</surname><given-names>PH</given-names></name><name><surname>Young</surname><given-names>DV</given-names></name><name><surname>Harpole</surname><given-names>DH</given-names></name><name><surname>Kaiser</surname><given-names>DL</given-names></name></person-group><article-title>Prognostic factors in head and neck melanoma: Effect of lesion location</article-title><source>Cancer</source><year>1988</year><volume>62</volume><fpage>831</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">3395962</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="F1" position="float"><label>Figure 1</label><caption><p>Photograph showing the ulcerated tumor of the eyelid hanging on the cheek</p></caption><alt-text>Figure 1</alt-text><graphic xlink:href="IndianJOphthalmol-56-239-g001"/></fig><fig id="F2" position="float"><label>Figure 2</label><caption><p>Histopathology showing skin with infiltrating melanin pigmentcontaining epithelioid tumor cells (Hematoxylin and Eosin &#x000d7;100)</p></caption><alt-text>Figure 2</alt-text><graphic xlink:href="IndianJOphthalmol-56-239-g002"/></fig></floats-group></article>